These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18840002)
21. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Imperiale TF; Birgisson S Ann Intern Med; 1997 Dec; 127(12):1062-71. PubMed ID: 9412308 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata. Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754 [TBL] [Abstract][Full Text] [Related]
24. Drugs for pH control in upper gastrointestinal bleeding. Brunner G; Luna P; Thiesemann C Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943 [TBL] [Abstract][Full Text] [Related]
25. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding. Mohamed SA; al Karawi MA Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305 [TBL] [Abstract][Full Text] [Related]
26. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. Huggins RM; Scates AC; Latour JK Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176 [TBL] [Abstract][Full Text] [Related]
27. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse. Camus M; Jensen DM; Kovacs TO; Jensen ME; Markovic D; Gornbein J Aliment Pharmacol Ther; 2016 May; 43(10):1080-9. PubMed ID: 27000531 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980 [TBL] [Abstract][Full Text] [Related]
29. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors. McCarthy DM Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788 [TBL] [Abstract][Full Text] [Related]
30. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers]. Geus WP; Lamers CB Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753 [TBL] [Abstract][Full Text] [Related]
31. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding. Barkun AN Drugs Today (Barc); 2003 Mar; 39 Suppl A():3-10. PubMed ID: 12712215 [TBL] [Abstract][Full Text] [Related]
32. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage. Martin RA Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242 [TBL] [Abstract][Full Text] [Related]
33. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. Ojiako K; Shingala H; Schorr C; Gerber DR Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic and therapeutic approach to upper gastrointestinal bleeding. Poddar U Paediatr Int Child Health; 2019 Feb; 39(1):18-22. PubMed ID: 30058470 [TBL] [Abstract][Full Text] [Related]
35. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Ghassemi KA; Kovacs TO; Jensen DM Curr Gastroenterol Rep; 2009 Dec; 11(6):462-9. PubMed ID: 19903422 [TBL] [Abstract][Full Text] [Related]
36. High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: Utility or futility? Primignani M; Tosetti G Dig Liver Dis; 2021 Mar; 53(3):387-388. PubMed ID: 33414085 [No Abstract] [Full Text] [Related]
37. Treatment of nonvariceal upper gastrointestinal bleeding. Rivkin K; Lyakhovetskiy A Am J Health Syst Pharm; 2005 Jun; 62(11):1159-70. PubMed ID: 15914876 [TBL] [Abstract][Full Text] [Related]
38. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility? Marmo R; Soncini M; Bucci C; Zullo A Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768 [No Abstract] [Full Text] [Related]
39. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Yang Z; Wu Q; Liu Z; Wu K; Fan D Digestion; 2011; 84(4):315-20. PubMed ID: 22075541 [TBL] [Abstract][Full Text] [Related]